|Exchange: ||NYSE||Stock Price ($): ||31.76|
|Industry: ||Major Drugs||Market Cap ($MM): ||34,810|
|Sector: ||Healthcare||Shares Outstanding (MM): ||1,096|
|BVR: ||Sales TTM ($MM): ||10,951|
|P/E: ||Short Interest Ratio (%): ||1.1900|
|Last Update: Feb 06, 2011 @ 09:00 pm|
|Eli Lilly & Company discovers, develops, manufactures and sells pharmaceutical products. The Company offers neuroscience products, endocrine products, anti-infectives, oncology products, animal health products and cardiovascular agents. Eli Lilly manufactures and distributes its products through owned or leased facilities in the United States, Puerto Rico and 26 other countries. The Company's products are sold in approximately 160 countries. Eli Lilly directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The Company also conducts research to find products to treat diseases in animals, and to increase the efficiency of animal food production.